Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Equity Income (2016 - 2025)

Historic Equity Income for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $5.2 million.

  • Surgery Partners' Equity Income changed 0.0% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year increase of 3742.69%. This contributed to the annual value of $19.5 million for FY2024, which is 3732.39% up from last year.
  • Per Surgery Partners' latest filing, its Equity Income stood at $5.2 million for Q3 2025, which was down 0.0% from $5.5 million recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' Equity Income peaked at $7.2 million during Q4 2024, and registered a low of $2.4 million during Q3 2022.
  • In the last 5 years, Surgery Partners' Equity Income had a median value of $3.3 million in 2023 and averaged $3.9 million.
  • As far as peak fluctuations go, Surgery Partners' Equity Income crashed by 1818.18% in 2024, and later skyrocketed by 10740.74% in 2025.
  • Over the past 5 years, Surgery Partners' Equity Income (Quarter) stood at $2.8 million in 2021, then soared by 57.14% to $4.4 million in 2022, then rose by 9.09% to $4.8 million in 2023, then skyrocketed by 50.0% to $7.2 million in 2024, then dropped by 27.78% to $5.2 million in 2025.
  • Its last three reported values are $5.2 million in Q3 2025, $5.5 million for Q2 2025, and $5.6 million during Q1 2025.